Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 22, 2025International Journal of Molecular SciencesOpen Access

IL-31/33 Axis in Atopic Dermatitis

View Full Paper
Ask AI
Bookmark
Share

Authors

JŁJulia ŁacwikKKKrzysztof KraikJLJulia Laska

Discussion

Loading...

Member takes

Overview

Review discusses IL-31/IL-33 axis's role in atopic dermatitis, highlighting the interaction with Th2 polarization.

Key Points

  • Elevated IL-31 and IL-33 levels correlate with atopic dermatitis severity, contributing to intense pruritus.
  • IL-33, released from keratinocytes, initiates inflammation and promotes Th2 cytokines like IL-4 and IL-13.
  • Targeting the IL-31/IL-33 axis could be a promising therapy, with agents like nemolizumab reducing symptoms effectively.
  • The variability of anti-IL-33 treatments suggests complexity in targeting this pathway for effective clinical outcomes.

Cite This Study

Łacwik et al. (2025) studied this question.

synapsesocial.com/papers/68f83321d24b29c969481d03https://doi.org/10.3390/ijms262010162
View Full Paper
Ask AI
Bookmark
Share